Summary
Over 250 branded drugs in the U.S. will see price increases starting Jan. 1, 2025, with most hikes below 10% and a median increase of 4.5%.
Key companies like Pfizer, Bristol Myers Squibb, and Sanofi are raising prices on treatments for COVID-19, cancer, and vaccines, citing R&D costs and inflation.
Some prices, such as Merck’s diabetes drugs, will be reduced.
Critics highlight that U.S. drug prices remain the highest globally, while manufacturers face pressure to moderate year-over-year price hikes.
See, this is why “Biden brought down drug prices. For 10 drugs. For Boomers only.” Isn’t a win.
“But did you think those boomers needed to pay $5 less for medicine? That’s a win! Now let’s have millions die of preventable illness because healthcare is a heavy tax burden on the middle class.”